Fluorescent serum and urinary advanced glycoxidation edn-paroducts in non-diabetic subjects

Biological Research

Volumn 40, Issue 2, 2007, Pages 203-212

  De la Maza, María Pía ^a,c   Bravo, A ^b   Leiva, L ^a   Gattas V ^a   Petermann, M ^a   Garrido, F ^a   Bunout, D ^a   Hirsch, S ^a   Barrera, G ^a   Fernandez M ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^c NONE

Author keywords

Advanced glycation end products; Fluorescent AGEs; Glycoxidation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; GLUCOSE; INSULIN; LEPTIN; LIPOPROTEIN;

ADULT; AGE; AGED; ANTHROPOMETRY; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; DIABETOGENESIS; DIETARY INTAKE; FEMALE; FLOW INJECTION ANALYSIS; FLUORESCENCE ANALYSIS; GEL PERMEATION CHROMATOGRAPHY; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; KIDNEY FUNCTION; LIPOPROTEIN BLOOD LEVEL; MALE; NUTRITIONAL ASSESSMENT; PROTEIN BLOOD LEVEL; URINE LEVEL; VOLUNTEER;

ADULT; AGED; BODY COMPOSITION; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET; FLUORESCENCE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPOPROTEINS; LYSINE; MALE; MIDDLE AGED; SPECTROMETRY, FLUORESCENCE;

EID: 36148939842     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BROWNLEE M (2000) Negative consequences of glycation. Metabolism 49 suppl 1: 9-3.
2. CAI W, GAO QD, ZHU L, PEPPA M, HE C, VLASSARA H (2002) Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med 8:337-46.
3. CHEN J, TAKAHASHI M, SUZUKI M, KUSHIDA K, MIYAMOTO S, INOUE S (1999) Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Rheumatology 38: 1275-1278.
4. DURNIN JV, WOMERSLEY J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97
5. FERRETTI G, BACCHETTI T, MORONI C, SAVINO S, LIUZZI A, BALZOLA F, BICCHIEGA V (2005) Paraoxonase activity in high density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab 3:1728-33.
6. GOLDBERG T, CAI W, PEPPA M, DARDAINE V, SURESH B, URIBARRII J, VLASSARA H (2004) Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 104: 1287-1291.
7. HEIN GE, KOHLER M, OELZNER P, STEIN G, FRANKE S (2005) The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Rheumatol Int 2:137-41.
8. HENLE T, DEPPISCH R, BECK W, HERGESELL O, HÄNSCH G, RITZ E (1999) Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol Dial Transplant 14: 1968-1975.
9. IWASHIGE K, KOUDA K, KOUDA M, HORIUCHI K, TAKAHASHI M, NAGANO A, TANAKA T, TAKEUCHI H (2004) Calorie restricted diet and urinary pentosidine in patients with rheumatoid arthritis. J Physiol Anthropol Appl Human Sci 23:19-24.
10. KALOUSOVA M, SULKOVA S, ZIMA T, DEPPISCH R, BECK W, BEDNAROVA V, FORTOVA M, TESAR V (2003) Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio. Ren Fail 25:277-86.
11. KALOUSOVA M, ZIMA T, POPOV P, SPACEK P, BRAUN M, SOUKUPOVA J, PELINKOVA K, KIENTSCH-ENGEL R (2004) Advanced glycation end-products in patients with chronic alcohol misuse. Alcohol Alcohol 39:316-20.
12. KRAJCOVIVOVÁ-KUDLACKOVÁ M, SEBEKOVÁ K, SCHINZEL RY, KLVANOVA J (2002) Advanced glycation end products and nutrition. Physiol Res 51: 313-316
13. MOLNAR D, DECSI T, KOLETZKO B (2004) Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes Relat Metab Disord 28:1197-202
14. MURTAGH-MARK CM, REISER KM, HARRIS R JR, MCDONALD RB (1995) Source of dietary carbohydrate affects life span of Fischer 344 rats independent of caloric restriction. J Gerontol A Biol Sci Med Sci 50:B148-54.
15. PEPPA M, URIBARRI J, CAI W, LU M, VLASSARA H (2004) Glycoxidation and inflammation in rena] failure patients. Am J Kidney Dis 43:690-5.
16. REISER KM (1994) Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymatic glycation of collagen in mice. J Gerontol 49:B71-9.
17. ROBERTS MA, THOMAS MC, FERNANDO D, MACMILLAN N, POWER DA, IERINO FL (2006) Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis. Nephrol Dial Transplant 21:1611-7
18. e-(carboxymethyl)lysine in human tissues in diabetes and ageing. J Clin Invest 99: 457-468.
19. URIBARRI J, CAI W, SANDU O, PEPPA M, GOLDBERG T, VLASSARA H (2005) Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann NY Acad Sci 1043: 461-466.
20. URIBARRI J, PEPPA M, CAI W, GOLDBERG T, LU M, VLASSARA H (2003) Restriction of glycotoxins markedly reduces AGE toxins in renal failure patients. J Am Soc Nephrol 14:728-731
21. UZUN H, ZENGIN K, TASKIN M, AYDIN S, SIMSEK G, DARIYERLI N (2004) Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg 14:659-65.
22. VITEK MP, BHATTACHARYA K, GLENDENING JM, STOPA E, VLASSARA H, BUCALA R, MANOGUE K, CERAMI A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91:4766-4770.
23. VLASSARA H, BROWNLEE M, CERAMI A (1986) Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem 32: 37-41.
24. VLASSARA H, CAI W, CRANDALL J, GOLDBERG T, OBERSTEIN R, DARDAINE V, PEPPA M, RAYFIELD EJ (2002) Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 26:15596-601
25. WROBEL K, WROBEL K, GARAY-SEVILLA ME, NAVA LE, MALACARA JM (1997) Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system. Clin Chem 43:1563-9
26. ZILIN S, NAIFENG L, BICHENG L, JIPING W (2001) The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy. Clin Chim Acta 313:69-75